Seattle Genetics Announces ADCETRIS (Brentuximab Vedotin) Approval in Japan for Frontline Hodgkin Lymphoma Read more
BeiGene Selects GE Healthcare’s Off-the-Shelf Biologics Factory to Boost its Manufacturing Capacity for Cancer Drugs Read more
Gilead and Galapagos Announce TORTUGA Phase 2 Study of Filgotinib in Ankylosing Spondylitis Achieves Primary Endpoint Read more
LEO Pharma Closes Acquisition of Bayer’s Prescription Dermatology Business in the United States Read more
Novartis to divest the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo Read more